Most of these TF have been described as overexpressed in different types of cancers, including ovarian, testis and breast cancer in the case of YBX237,38, and breast cancer, lung cancer and acute myeloid leukemia in the case of EYA239,40. This evidence concerns the gene TF and breast cancer.